These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24894672)

  • 1. CD24 single nucleotide polymorphisms and cancer risk.
    Yan S; Xu D; Jiang T; Wang P; Yin Y; Wang X; Hua C; Zhang B; Li Z; Lu L; Liu X; Wang B; Zhang D; Zhang R; Sun B; Wang X
    Tumour Biol; 2014 Sep; 35(9):8927-32. PubMed ID: 24894672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study].
    Zhou X; Cao Y; Luo J; Zeng X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1122-9. PubMed ID: 24316932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
    Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
    Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
    [No Abstract]   [Full Text] [Related]  

  • 4. CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
    Zhou X
    Clin Breast Cancer; 2014 Apr; 14(2):e33-40. PubMed ID: 24393851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
    Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
    World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.
    Huang M; Xiao J; Zhao X; Liu C; Chen Q
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):431-8. PubMed ID: 21906115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24 is a genetic modifier for risk and progression of prostate cancer.
    Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
    Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
    Lee YH; Bae SC
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):97-104. PubMed ID: 26718436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CD24 and the adenomatous polyposis coli gene polymorphisms with oral lichen planus.
    Kaplan I; Nabiochtchikov I; Leshno A; Moshkowitz M; Shlomi B; Kleinman S; Dagan Y; Meshiach Y; Galazan L; Arber N; Avivi-Arber L; Kraus S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):378-85. PubMed ID: 26187149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 polymorphisms in breast cancer: impact on prognosis and risk.
    Buck K; Hug S; Seibold P; Ferschke I; Altevogt P; Sohn C; Schneeweiss A; Burwinkel B; Jäger D; Flesch-Janys D; Chang-Claude J; Marmé F
    Breast Cancer Res Treat; 2013 Feb; 137(3):927-37. PubMed ID: 23314606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dinucleotide Deletion in the
    Segev L; Naboishchikov I; Kazanov D; Bernstein E; Shaked M; Arber N; Shapira S
    Am Surg; 2020 May; 86(5):480-485. PubMed ID: 32684047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis.
    Diaz-Gallo LM; Medrano LM; Gómez-García M; Cardeña C; Rodrigo L; Mendoza JL; Taxonera C; Nieto A; Alcain G; Cueto I; López-Nevot MA; Urcelay E; Martin J
    Hum Immunol; 2011 Oct; 72(10):969-72. PubMed ID: 21684315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.
    Huang XL; Xu DH; Wang GP; Zhang S; Yu CG
    World J Gastroenterol; 2015 May; 21(19):6052-9. PubMed ID: 26019472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis.
    Yao F; Yan S; Wang X; Shi D; Bai J; Li F; Sun B; Qian B
    Tumour Biol; 2014 Sep; 35(9):9061-8. PubMed ID: 24913709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
    Li Z; Wang J; Wang F; Ma Z; Yu Z
    Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of CD24 polymorphisms to autoimmune disease: A meta-analysis.
    Baek J; Kang S; Byeon H; Woo Hwang K; Min H
    Comput Biol Med; 2015 Sep; 64():268-75. PubMed ID: 26245161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
    Hu Z; Li X; Yuan R; Ring BZ; Su L
    Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.